TY - JOUR
T1 - Genetic susceptibility to diabetic kidney disease is linked to promoter variants of XOR
AU - Wang, Qin
AU - Qi, Haiying
AU - Wu, Yiming
AU - Yu, Liping
AU - Bouchareb, Rihab
AU - Li, Shuyu
AU - Lassén, Emelie
AU - Casalena, Gabriella
AU - Stadler, Krisztian
AU - Ebefors, Kerstin
AU - Yi, Zhengzi
AU - Shi, Shaolin
AU - Salem, Fadi
AU - Gordon, Ronald
AU - Lu, Lu
AU - Williams, Robert W.
AU - Duffield, Jeremy
AU - Zhang, Weijia
AU - Itan, Yuval
AU - Böttinger, Erwin
AU - Daehn, Ilse
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2023/4
Y1 - 2023/4
N2 - The lifetime risk of kidney disease in people with diabetes is 10–30%, implicating genetic predisposition in the cause of diabetic kidney disease (DKD). Here we identify an expression quantitative trait loci (QTLs) in the cis-acting regulatory region of the xanthine dehydrogenase, or xanthine oxidoreductase (Xor), a binding site for C/EBPβ, to be associated with diabetes-induced podocyte loss in DKD in male mice. We examine mouse inbred strains that are susceptible (DBA/2J) and resistant (C57BL/6J) to DKD, as well as a panel of recombinant inbred BXD mice, to map QTLs. We also uncover promoter XOR orthologue variants in humans associated with high risk of DKD. We introduced the risk variant into the 5′-regulatory region of XOR in DKD-resistant mice, which resulted in increased Xor activity associated with podocyte depletion, albuminuria, oxidative stress and damage restricted to the glomerular endothelium, which increase further with type 1 diabetes, high-fat diet and ageing. Therefore, differential regulation of Xor contributes to phenotypic consequences with diabetes and ageing.
AB - The lifetime risk of kidney disease in people with diabetes is 10–30%, implicating genetic predisposition in the cause of diabetic kidney disease (DKD). Here we identify an expression quantitative trait loci (QTLs) in the cis-acting regulatory region of the xanthine dehydrogenase, or xanthine oxidoreductase (Xor), a binding site for C/EBPβ, to be associated with diabetes-induced podocyte loss in DKD in male mice. We examine mouse inbred strains that are susceptible (DBA/2J) and resistant (C57BL/6J) to DKD, as well as a panel of recombinant inbred BXD mice, to map QTLs. We also uncover promoter XOR orthologue variants in humans associated with high risk of DKD. We introduced the risk variant into the 5′-regulatory region of XOR in DKD-resistant mice, which resulted in increased Xor activity associated with podocyte depletion, albuminuria, oxidative stress and damage restricted to the glomerular endothelium, which increase further with type 1 diabetes, high-fat diet and ageing. Therefore, differential regulation of Xor contributes to phenotypic consequences with diabetes and ageing.
UR - http://www.scopus.com/inward/record.url?scp=85152009612&partnerID=8YFLogxK
U2 - 10.1038/s42255-023-00776-0
DO - 10.1038/s42255-023-00776-0
M3 - Article
C2 - 37024752
AN - SCOPUS:85152009612
SN - 2522-5812
VL - 5
SP - 607
EP - 625
JO - Nature Metabolism
JF - Nature Metabolism
IS - 4
ER -